COPA expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.853600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.568200E-01
Normal-vs-Stage2
5.351600E-01
Normal-vs-Stage3
4.365200E-01
Normal-vs-Stage4
1.827050E-01
Stage1-vs-Stage2
8.040200E-01
Stage1-vs-Stage3
2.316000E-01
Stage1-vs-Stage4
1.623400E-01
Stage2-vs-Stage3
1.094380E-01
Stage2-vs-Stage4
5.017900E-02
Stage3-vs-Stage4
6.955500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.587200E-01
Normal-vs-AfricanAmerican
7.764000E-02
Normal-vs-Asian
4.632200E-01
Caucasian-vs-AfricanAmerican
3.388000E-02
Caucasian-vs-Asian
2.775800E-01
AfricanAmerican-vs-Asian
3.858800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.950600E-01
Normal-vs-Female
5.742000E-01
Male-vs-Female
7.928800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.730600E-01
Normal-vs-Age(41-60Yrs)
3.506000E-01
Normal-vs-Age(61-80Yrs)
6.717600E-01
Normal-vs-Age(81-100Yrs)
9.370000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.753600E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.439600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.378400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.974100E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.975600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.162800E-01
Normal-vs-Daily Drinker
5.975000E-01
Normal-vs-Weekly Drinker
5.451400E-01
Normal-vs-Occasional Drinker
3.465000E-01
Normal-vs-Social Drinker
2.955800E-01
Non Drinker-vs-Daily Drinker
1.809210E-01
Non Drinker-vs-Weekly Drinker
3.689800E-01
Non Drinker-vs-Occasional Drinker
5.157600E-02
Non Drinker-vs-Social Drinker
8.592200E-02
Daily Drinker-vs-Weekly Drinker
5.257600E-02
Daily Drinker-vs-Occasional Drinker
5.839000E-03
Daily Drinker-vs-Social Drinker
7.421400E-03
Weekly Drinker-vs-Occasional Drinker
3.616000E-01
Weekly Drinker-vs-Social Drinker
4.658000E-01
Occasional Drinker-vs-Social Drinker
7.671000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.570000E-01
Normal-vs-Grade 2
5.711700E-02
Normal-vs-Grade 3
6.688200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.610760E-01
Grade 1-vs-Grade 3
2.779000E-01
Grade 1-vs-Grade 4
2.570000E-01
Grade 2-vs-Grade 3
8.360800E-01
Grade 2-vs-Grade 4
5.711700E-02
Grade 3-vs-Grade 4
6.688200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.423400E-01
Normal-vs-NonDiabetic
5.854600E-01
Diabetic-vs-NonDiabetic
5.440400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.800600E-01
Normal-vs-NoPancreatitis
6.807800E-01
Pancreatitis-vs-NoPancreatitis
8.908800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.227400E-01
Normal-vs-N1
5.836000E-01
N0-vs-N1
5.424000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.279800E-01
Normal-vs-TP53-NonMutant
5.745800E-01
TP53-Mutant-vs-TP53-NonMutant
1.826160E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
